According to researchers, probiotics can help relieve symptoms of depression, as well as be beneficial in helping to treat IBS.
Eating processed food which contains Propionic Acid (PPA) during pregnancy may affect neural stem cell development in the fetal brain. Excessive PPA reduces the number of neurons and over-produces glial cells, causing inflammation. Additionally, PPA shortens neural pathways. The combination of damaged pathways and reduced neurons may be associated with behavioral deficits associated with ASD.
Researchers report cells located in the gut spark an immune response that protects neurons against damage connected to Parkinson's.
Researchers report transgenic mice engineered to carry genes associated with ALS showed improved neuromuscualr function and lived longer after being exposed to butyrate.
Researchers report activating microglia may help reduce the imbalance between neuroprotection and neurotoxicity for neurodegenerative diseases.
A new study reports gut bacteria drives the formation of cerebral cavernous malformations.
Genetic mutations, which occur in both the brain and gut, could be a main cause of autism. Using mouse models of ASD, researchers discovered the neuroligin-3 R451C mutation affects neural communication in the brain and causes dysfunction in the gut. The findings strengthen the gut-brain hypothesis of autism.
A new review of almost 200 publications suggests the gut microbiota may play a critical role in modulating brain function, social behavior and other symptoms of autism.
B. longum APC1472 reduces blood glucose levels and reduces weight gain in mouse models. The bacteria also keep ghrelin, a hormone associated with hunger, and the stress hormone cortisol in check.
Examining the gut microbiome of those with major depressive disorder, researchers identify the presence of the bacteria Faecalibacterium prausnitzii as being responsible for the functional discrepancies between healthy individuals and those with MDD.
A new study reveals researchers were able to distinguish between children with or without ASD diagnosis, thanks to a new saliva based biomarker panel. Researchers report the test can be used in children as young as 18 month, assisting in early diagnosis of autism.